Navigation Links
Rentschler Biotechnologie erweitert Kapazitten fr Produktion in Sugetierzellen
Date:6/20/2008

arktsegment. Seit 2001 hat sich dabei die Zahl der Beschäftigten nahezu verdreifacht und umfasst heute ca. 350 Mitarbeiter.


Über Rentschler Biotechnologie – www.rentschler.de
Rentschler Biotechnologie GmbH ist Teil der im Privatbesitz befindlichen Rentschler Gruppe mit Sitz in Laupheim, Deutschland. Als internationales Full-Service-Auftragsunternehmen mit 350 hochqualifizierten Mitarbeitern hat Rentschler Biotechnologie umfangreiche und langjährige Erfahrung mit der Entwicklung, Produktion und Zulassung von in Zellkultur hergestellten Biopharmazeutika, konform mit den internationalen GMP-Standards. Zum Servicespektrum des Unternehmens gehören auch die Zulassungsberatung und Fill & Finish.

Kontakt:
Dr. Wieland Wolf
Dr. Rentschler Holding GmbH & Co. KG
Phone: +49 (0)7392-701-0
e-mail: presse@rentschler.de

Medien Kontakt:
Friederike Braun
Phone: +49 (0)7392 701–555
e-mail: friederike.braun@rentschler.de


'/>"/>
www.b3c.de

Page: 1 2

Related biology technology :

1. Rentschler Biotechnologie Announces Cooperation with Boehringer Ingelheim
2. Rentschler Biotechnologie Extends Capacities for Mammalian Cell Culture Manufacturing
3. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
4. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
5. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
6. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
7. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
8. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
9. Amyris Biotechnologies Announces $70 Million Series B Round
10. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
11. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 29, 2015 , ... The new Xsample 530 sample changer for vials ... range of liquid viscosities – from less than 12,000 mPas (internal air) up to 36,000 ... , What immediately catches the eye about Xsample 530 is its removable magazine, which is ...
(Date:7/28/2015)... YORK , July 28, 2015 People ... by hearing aids achieved significant and sometimes profound improvements ... cochlear implant devices, according to a new multicenter study ... In the study, described online ahead of print in ... medical centers and private clinics in the ...
(Date:7/28/2015)... ... July 28, 2015 , ... In terms of ... 2013; while production volume reached close to 1.84 million tonnes in the same ... of 75.5% of the region’s total aluminium hydroxide production; the country’s aluminium hydroxide ...
(Date:7/28/2015)... July 21, 2015 Research and Markets ... the "Biomedical Refrigerators and Freezers Market - ... Forecast 2014 - 2022" report to their ... and freezers market has been segmented based on ... banks, and others. The others segment includes applications ...
Breaking Biology Technology:New Moves in Automatic Sample Handling: Introducing Xsample 530 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 3Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 3
... Feb. 23, 2011 Talecris Biotherapeutics Holdings Corp. ("Talecris") ... results for the three and twelve months ended December ... U.S. Securities and Exchange Commission (SEC). Fourth ... 5.3% to $410.8 million from $390.1 million in the ...
... Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company developing ... today announced that it holds the license, from the ... to a clinically active oncology vaccine directed to multiple ... Dr. Hideho Okada, Associate Professor of Neurological Surgery and ...
... JOLLA, Calif., Feb. 23, 2011 The ... providing personalized treatment information to women with ovarian ... appointed Executive Director, a new position for the ... lead the foundation as it increases its capacity ...
Cached Biology Technology:Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 2Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 3Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 4Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 5Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 6Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 7Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 8Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 9Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 10Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 11Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 12Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 13Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 14Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 15Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 16Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 17Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 18Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 19Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 20Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 21Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 22Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 23Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 24Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 25Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 26Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 27Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results 28Stemline Therapeutics Licenses Phase I/II Brain Cancer Vaccine - Shows Promise in Clinical Trial Conducted at University of Pittsburgh 2Stemline Therapeutics Licenses Phase I/II Brain Cancer Vaccine - Shows Promise in Clinical Trial Conducted at University of Pittsburgh 3The Clearity Foundation Hires Hillary Theakston as Executive Director 2The Clearity Foundation Hires Hillary Theakston as Executive Director 3
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
(Date:7/13/2015)... Jul. 13, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD ... convenient and secure method to make payments.  With ... methods, introduced with its groundbreaking voice-direct payment patent ...
(Date:7/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced a new Match-in-Sensor™ ... hardware encapsulated fingerprint sensor and matching solution. ... literally off the grid, isolating fingerprint image ... the fingerprint sensor to provide ultimate protection ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... CAMBRIDGE, MA (09/05/07)--It is well established that a child,s ... continues about the extent to which such plasticity exists ... from MIT and Johns Hopkins University have used converging ... that the adult visual cortex does indeed reorganize-and that ...
... Allianz Foundation for North America today announced a new ... now residing in nine U.S. cities to assess the ... As these displaced students know from being on ... said Dr. Lara Hansen chief climate scientist, World Wildlife ...
... The Simons Foundation, through its Autism Research Initiative, has ... University Cell and DNA Repository (RUCDR) to establish a ... will be collected from 2,000 families that have a ... this project is known, will constitute the core resource ...
Cached Biology News:Adult brain can change, study confirms 2Opportunity for students displaced by Katrina to assess climate vulnerability of Southeast US 2Rutgers Genetics receives $7.8 million for autism research 2Rutgers Genetics receives $7.8 million for autism research 3